Delivery Order SPE2DB20D1004-SPE2DB24FF5E1

Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,340,677 units of Methylphenidate ER 54 mg Tablets in 100-count bottles. The Firm Fixed Price contract has a ceiling value of $3,994.02 and a completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,714,237 units of Methylphenidate ER 36 mg tablets in 100-count bottles, with a ceiling value of $1,580.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 27, 2025. This contract award is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,229,618 units of Methylphenidate ER 36 mg tablets. The contract has a ceiling value of $1,140.06 and a period of performance through February 12, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,567,785,629 units of Methylphenidate ER 36 mg tablets in 100-count packages. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,217.04 and an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,760,196 units of Methylphenidate ER 18 mg tablets in 100-count packages, with a total ceiling value of $1,209.06. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,618,148 units of Methylphenidate ER 18 mg tablets. The $1,328.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through March 19, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,510,706 units of Methylphenidate ER 18 mg tablets in 100-count packages. The Firm Fixed Price contract, valued at $1,613.35, has a completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,244,766 units of Methylphenidate ER 18 mg tablets. The $4,659.60 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a large pharmaceutical distributor. The contract is for the delivery of 4,563,982,183 units of Methylphenidate ER 27 mg tablets in 100-count bottles, with a ceiling value of $2,696.58. The contract is a firm fixed price delivery order, with a period of performance through March 18, 2024. No set-aside designation was used for this award....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF5E1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,563,828,550 units of Methylphenidate ER 27 mg tablets in 100-count bottles, with a total ceiling value of $1,168.67. The contract has a firm fixed price and will run through March 4, 2024.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award did not utilize any set-aside designations, indicating open competition.

Generated 2/27/25, 9:47 AM